Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3859 ARTÍCULOS , VIENDO DEL 571 AL 585

Antiseizure Drugs and Movement Disorders

Sáenz-Farret M, Tijssen MAJ, Eliashiv D, Fisher RS, Sethi K, Fasano A.

CNS Drugs. 2022 Aug;36(8):859-876. doi: 10.1007/s40263-022-00937-x. Epub 2022 Jul 21.

GSK-3β-mediated regulation of Nrf2/HO-1 signaling as a new therapeutic approach in the treatment of movement disorders

Soni D, Kumar P.

Pharmacol Rep. 2022 Aug;74(4):557-569. doi: 10.1007/s43440-022-00390-z. Epub 2022 Jul 26.

Severe rhabdomyolysis in neuronal ceroid lipofuscinosis type 7

Sürücü Kara İ, Köse E, Doğulu N, Yüksel MF, Ceylaner S, Kendirli T, Eminoğlu FT.

Clin Neurol Neurosurg. 2022 Sep;220:107375. doi: 10.1016/j.clineuro.2022.107375. Epub 2022 Jul 20.

Monocentric retrospective clinical outcome in a group of 13 patients with opsoclonus myoclonus syndrome, proposal of diagnostic algorithm and review of the literature

Urtiaga Valle S, Souvannanorath S, Leboucq N, Haouy S, Rivier F, Roubertie A, Meyer P.

Eur J Paediatr Neurol. 2022 Sep;40:18-27. doi: 10.1016/j.ejpn.2022.07.002. Epub 2022 Jul 13.

NUS1 and Epilepsy-myoclonus-ataxia Syndrome: An Under-recognized Entity?

Riboldi GM, Monfrini E, Stahl C, Frucht SJ.

Tremor Other Hyperkinet Mov (N Y). 2022 Jun 15;12:21. doi: 10.5334/tohm.696. eCollection 2022.

Palato-Pharyngo-Laryngeal Rhythmic Myoclonus in Neuro-Behcet Syndrome: A Case Report

Kothari DS, Tanenbaum ZG, Abdel-Wahed L, Cho TA, Hoffman HT.

Ann Otol Rhinol Laryngol. 2023 Aug;132(8):959-963. doi: 10.1177/00034894221120124. Epub 2022 Aug 23.

Breast Cancer Presenting As Onconeural Antibody Negative Opsoclonus-Myoclonus Syndrome

Soares R, Mittapalli A, Ramakrishnan M, Farooq U.

Cureus. 2022 Aug 25;14(8):e28417. doi: 10.7759/cureus.28417. eCollection 2022 Aug.

Hashimoto's encephalopathy with cerebellar ataxia as the main symptom: A case report and literature review

Wei C, Shen Y, Zhai W, Shang T, Wang Z, Wang Y, Li M, Zhao Y, Sun L.

Front Neurol. 2022 Aug 23;13:970141. doi: 10.3389/fneur.2022.970141. eCollection 2022.

Post-COVID-19 Myoclonus-Ataxia Syndrome Responsive to Intravenous Immunoglobulins

Godani M, Beronio A, Lanza G.

Mov Disord Clin Pract. 2022 Sep 11;9(Suppl 2):S6-S8. doi: 10.1002/mdc3.13534. eCollection 2022 Sep.

Pearls & Oy-sters: SCA21 Due to TMEM240 Variation Presenting as Myoclonus Dystonia Syndrome

Cherian A, K P D, Vijayaraghavan A, Krishnan S.

Neurology. 2022 Sep 20;99(12):531-534. doi: 10.1212/WNL.0000000000201015. Epub 2022 Jul 8.

Rare Etiologies in Immune-Mediated Cerebellar Ataxias: Diagnostic Challenges

Hadjivassiliou M, Manto M, Mitoma H.

Brain Sci. 2022 Aug 30;12(9):1165. doi: 10.3390/brainsci12091165.

DDOST-CDG: Clinical and molecular characterization of a third patient with a milder and a predominantly movement disorder phenotype

Elsharkawi I, Wongkittichote P, Daniel EJP, Starosta RT, Ueda K, Ng BG, Freeze HH, He M, Shinawi M.

J Inherit Metab Dis. 2023 Jan;46(1):92-100. doi: 10.1002/jimd.12565. Epub 2022 Oct 17.

Accidental Falls in Patients with Hyperkinetic Movement Disorders: A Systematic Review

Homann CN, Homann B, Ivanic G, Urbanic-Purkart T.

Tremor Other Hyperkinet Mov (N Y). 2022 Oct 7;12:30. doi: 10.5334/tohm.709. eCollection 2022.

Adult-onset Krabbe disease presenting with progressive myoclonic epilepsy and asymmetric occipital lesions: A case report

Wang Y, Wang SY, Li K, Zhu YL, Xia K, Sun DD, Ai WL, Fu XM, Ye QR, Li J, Chen HZ.

Front Neurol. 2022 Oct 21;13:1010150. doi: 10.3389/fneur.2022.1010150. eCollection 2022.

Myoclonus status revealing COVID 19 infection

Ben Mohamed D, Zouari R, Ketata J, Nabli F, Blel S, Ben Sassi S.

Seizure. 2023 Jan;104:12-14. doi: 10.1016/j.seizure.2022.11.010. Epub 2022 Nov 22.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias